Page last updated: 2024-12-07

kg 501

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

naphthol AS-E phosphate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID87517
CHEMBL ID1234585
SCHEMBL ID11979377
MeSH IDM0480221

Synonyms (37)

Synonym
CHEMBL1234585
n3p ,
n-(4-chlorophenyl)-3-(phosphonooxy)naphthalene-2-carboxamide
naphthol as-e phosphate
DB08240
18228-17-6
nsc746568
nsc-746568
[3-[(4-chlorophenyl)carbamoyl]naphthalen-2-yl] dihydrogen phosphate
naphtholas-ephosphate
unii-h6r6b93qfc
h6r6b93qfc ,
einecs 242-106-1
nsc 746568
kg 501
kg-501
S8409
AKOS024375425
SCHEMBL11979377
DTXSID10171275
naphthol as-e phosphate, for histology
mfcd00042718
CS-0027313
HY-103299
3-(4-chlorophenylcarbamoyl)naphthalen-2-yl dihydrogen phosphate
3-[(4-chlorophenyl)carbamoyl]naphthalen-2-yl dihydrogen phosphate
FT-0712758
kg-501(naphthol as-e phosphate)
Q27097463
HMS3886J10
BCP29194
EX-A2026
C73512
3-((4-chlorophenyl)carbamoyl)naphthalen-2-yl dihydrogen phosphate ,
kg-501 (2-naphthol-as-e-phosphate)
AC-35586
dibenzylterephthalate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1413754Inhibition of [32P]-labeled CREB KID (unknown origin) binding to GST-fused mouse CBP KIX domain preincubated with GST-fused CBP for 15 mins followed by CREB addition and measured after 30 mins by SDS-gel electrophoresis/autoradiographic method2018MedChemComm, Aug-01, Volume: 9, Issue:8
Chemical modulation of transcription factors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's8 (66.67)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.43 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index50.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]